(Q35027930)

English

Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

Europe PubMed Central

Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

pharmacokinetics

1 reference

based on heuristic

inferred from title

James W. Paxton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Shufeng Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Philip Kestell

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Drug Metabolism Reviews

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

751-790

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Screening for human ADME/Tox drug properties in drug discovery

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Inter-species differences in drug properties

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Physiological pharmacokinetic modelling

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Structural and functional studies of UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Flavone acetic acid--preclinical and clinical activity

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Effect of flavone acetic acid (NSC 347,512) on splenic cytotoxic effector cells and their role in tumour necrosis.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Extrahepatic metabolism of drugs in humans

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Structure and function of uridine diphosphate glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Inherited variations in drug-metabolizing enzymes: significance in clinical oncology

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Update: genetic polymorphism of drug metabolizing enzymes in humans

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Microsomal enzyme induction

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Inhibition and induction of human cytochrome P450 (CYP) enzymes

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Interindividual variability in inhibition and induction of cytochrome P450 enzymes

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Species differences in the metabolism of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in vitro: implications for prediction of metabolic interactions in vivo

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Glucuronidation of diflunisal in liver and kidney microsomes of rat and man.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Drug glucuronidation by human renal UDP-glucuronosyltransferases.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Biological basis for extrapolation across mammalian species.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Measurement of nanogram quantities of UDP-glucuronic acid in tissues

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5?-diphosphoglucuronic acid in human tissues

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Selective inhibitors of cytochromes P450.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Stereoselective binding properties of naproxen glucuronide diastereomers to proteins

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Reactivity of flavone acetic acid and its acyl glucuronide

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Predictability of the covalent binding of acidic drugs in man.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Irreversible binding of zomepirac to plasma protein in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Plasma protein binding and pharmacological response

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Dosage regimen design for pharmaceutical studies conducted in animals.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Incorporation of in vitro drug metabolism data into physiologically-based pharmacokinetic models

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

In vitro approaches to predicting drug interactions in vivo.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Bosentan, a new endothelin receptor antagonist: prediction of the systemic plasma clearance in man from combined in vivo and in vitro data

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Hepatic drug-metabolizing enzymes in lung tumor-bearing rats.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Quantitative structure-activity relationships in substrates, inducers, and inhibitors of cytochrome P4501 (CYP1).

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

ADME/PK as part of a rational approach to drug discovery

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Use of in vitro human metabolism studies in drug development. An industrial perspective

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Advances in drug metabolism screening

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512)

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

The structure and function of the UDP-glucuronosyltransferase gene family

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Preclinical approach for identifying drug interactions

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Disposition of the novel antitumour agent xanthenone-4-acetic acid in the mouse: identification of metabolites and routes of elimination

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Determination of two major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in hepatic microsomal incubations by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat and rabbit

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

The effect of various potential inhibitors, activators and inducers on theN-oxidation of 3-substituted pyridinesin vitro

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trial

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Genotoxicity of acyl glucuronide metabolites formed from clofibric acid and gemfibrozil: a novel role for phase-II-mediated bioactivation in the hepatocarcinogenicity of the parent aglycones?

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteins

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Determination of unbound concentration of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detection

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120015693

21 January 2018

Identifiers

10.1081/DMR-120015693

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12487149%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35027930&oldid=2144573084"